stockportfolio.pro
BioMarin Pharmaceutical Inc. Net Income 2008–2025
BioMarin Pharmaceutical Inc. (BMRN) annual net income by fiscal year, computed from SEC filings. Compound growth +15.3%/yr over 17 years.
| Fiscal year | Net Income | Net margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $348.90M | 10.8% | -18.3% |
| FY 2024 | $426.86M | 15.0% | +154.6% |
| FY 2023 | $167.65M | 6.9% | +18.4% |
| FY 2022 | $141.56M | 6.8% | +320.9% |
| FY 2021 | $-64.08M | -3.5% | -107.5% |
| FY 2020 | $854.03M | 45.9% | +3681.1% |
| FY 2019 | $-23.85M | -1.4% | +69.1% |
| FY 2018 | $-77.21M | -5.2% | +34.0% |
| FY 2017 | $-117.04M | -8.9% | +81.4% |
| FY 2016 | $-630.21M | -56.4% | -266.8% |
| FY 2015 | $-171.80M | -19.3% | -28.2% |
| FY 2014 | $-133.97M | -17.9% | +24.0% |
| FY 2013 | $-176.35M | -32.2% | -54.2% |
| FY 2012 | $-114.35M | -22.8% | -112.4% |
| FY 2011 | $-53.84M | -12.2% | -126.2% |
| FY 2010 | $205.82M | 54.7% | +42276.0% |
| FY 2009 | $-488,000 | -0.2% | -101.6% |
| FY 2008 | $30.83M | 10.4% | — |
Source: BioMarin Pharmaceutical Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for BioMarin Pharmaceutical Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeBioMarin Pharmaceutical Inc. — frequently asked questions
What is BioMarin Pharmaceutical Inc.'s net income?
BioMarin Pharmaceutical Inc. (BMRN) reported net income of $348.90M for fiscal year 2025, per its SEC filings.
How has BioMarin Pharmaceutical Inc.'s net income changed over time?
Between fiscal 2008 and 2025, BMRN's net income grew at roughly 15.3% per year (compound annual rate), from $30.83M to $348.90M.
Where does this data come from?
Figures are computed from BioMarin Pharmaceutical Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.